Bio-Rad Introduces The Geenius HIV 1/2 Confirmatory System
09 May 2013

Bio-Rad Laboratories, Inc., has announced the release of Geenius™ HIV 1/2 Confirmatory for markets outside the US (US clinical trials start in June).

The Geenius™ HIV 1/2 Confirmatory is a complete system that provides unitary HIV-1 and HIV-2 confirmation and differentiation in serum, plasma, or whole blood along with automated reading and interpretation of the results - all in less than 30 minutes.

Key benefits of the system include unitary and immediate testing, HIV confirmation and differentiation testing in less than 30 minutes, ability to process 3 sample types (serum, plasma, whole blood). The software is easy to use, with a validated algorithm and the system provides full traceability.

Request Info


Company website

Tags: HIV/AIDS

Bio-Rad
profile photo

Sonia Nicholas
Clinical Diagnostics Editor